{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T14:26:16Z","timestamp":1790691976296,"version":"4.1.0"},"reference-count":163,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T00:00:00Z","timestamp":1778803200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T00:00:00Z","timestamp":1778803200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100016252","name":"Research Services and Knowledge Transfer Office, University of Macau","doi-asserted-by":"publisher","award":["MYRG-GRG2024-00097-ICMS-UMDF"],"award-info":[{"award-number":["MYRG-GRG2024-00097-ICMS-UMDF"]}],"id":[{"id":"10.13039\/501100016252","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006469","name":"Fundo para o Desenvolvimento das Ci\u00eancias e da Tecnologia","doi-asserted-by":"publisher","award":["0052\/2022\/A1"],"award-info":[{"award-number":["0052\/2022\/A1"]}],"id":[{"id":"10.13039\/501100006469","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Guangdong-Hong Kong-Macao Joint Laboratory for New Drug Screening","award":["2023B121212000"],"award-info":[{"award-number":["2023B121212000"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Chin Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Depression is a prevalent  and debilitating psychiatric disorder that is frequently  accompanied by chronic conditions such as cancer, cardiovascular diseases, and neurological disorders. Despite the availability of various pharmacological treatments, their limited efficacy and frequent side effects have prompted growing interest in natural compounds with antidepressant potential.\n                    <jats:italic>Panax ginseng<\/jats:italic>\n                    , a traditional herbal medicine widely used in East Asia, contains diverse bioactive components, among which ginsenosides are recognized as the principal active constituents. Ginsenosides, primarily classified into dammarane-type and oleanane-type saponins, exhibit antidepressant-like effects through multiple interconnected biological mechanisms. These include modulation of monoaminergic neurotransmission, regulation of the hypothalamic\u2013pituitary\u2013adrenal (HPA) axis, promotion of neurogenesis and synaptic plasticity, mitigation of neuroinflammation and oxidative stress, and restoration of gut microbiota homeostasis. Recent investigations also highlight enhanced bioavailability and therapeutic promises of rare ginsenosides, such as ginsenosides\u00a0Rg3, Rk1 and Rg5, with fewer sugar moieties, suggesting unique advantages for clinical application. This review consolidates current evidence on the pharmacological activities, molecular targets, and therapeutic potential of ginsenosides in the management of depression. By integrating findings from experimental and limited clinical studies, it aims to provide a rational scientific framework to inform future investigation and development of ginsenoside-based strategies for depression, while emphasizing the need for further rigorous clinical validation.\n                  <\/jats:p>","DOI":"10.1186\/s13020-026-01416-x","type":"journal-article","created":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T13:58:48Z","timestamp":1778853528000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Ginsenosides in the management of depression: a comprehensive pharmacological review"],"prefix":"10.1186","volume":"21","author":[{"given":"Min","family":"Ren","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-Chang","family":"Bi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon Ming-Yuen","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Bo","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,15]]},"reference":[{"key":"1416_CR1","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/s41572-020-0200-2","volume":"6","author":"SM Gold","year":"2020","unstructured":"Gold SM, Kohler-Forsberg O, Moss-Morris R, Mehnert A, Miranda JJ, Bullinger M, et al. Comorbid depression in medical diseases. Nat Rev Dis Primers. 2020;6:69.","journal-title":"Nat Rev Dis Primers"},{"key":"1416_CR2","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/s41572-023-00454-1","volume":"9","author":"W Marx","year":"2023","unstructured":"Marx W, Penninx BW, Solmi M, Furukawa TA, Firth J, Carvalho AF, et al. Major depressive disorder. Nat Rev Dis Primers. 2023;9:44.","journal-title":"Nat Rev Dis Primers"},{"key":"1416_CR3","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1007\/s11920-023-01423-x","volume":"25","author":"KL Lovero","year":"2023","unstructured":"Lovero KL, Dos Santos PF, Come AX, Wainberg ML, Oquendo MA. Suicide in global mental health. Curr Psychiatry Rep. 2023;25:255\u201362.","journal-title":"Curr Psychiatry Rep"},{"key":"1416_CR4","doi-asserted-by":"publisher","first-page":"524","DOI":"10.3390\/jcm11030524","volume":"11","author":"V Visco","year":"2022","unstructured":"Visco V, Vitale C, Rispoli A, Izzo C, Virtuoso N, Ferruzzi GJ, et al. Post-COVID-19 syndrome: involvement and interactions between respiratory, cardiovascular and nervous systems. J Clin Med. 2022;11:524.","journal-title":"J Clin Med"},{"key":"1416_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2021.153669","volume":"90","author":"XL Wang","year":"2021","unstructured":"Wang XL, Feng ST, Wang YT, Chen NH, Wang ZZ, Zhang Y. Paeoniflorin: a neuroprotective monoterpenoid glycoside with promising anti-depressive properties. Phytomedicine. 2021;90:153669.","journal-title":"Phytomedicine"},{"key":"1416_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.fitote.2023.105514","volume":"167","author":"W Xu","year":"2023","unstructured":"Xu W, Lyu W, Duan C, Ma F, Li X, Li D. Preparation and bioactivity of the rare ginsenosides Rg3 and Rh2: an updated review. Fitoterapia. 2023;167:105514.","journal-title":"Fitoterapia"},{"key":"1416_CR7","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.jgr.2020.02.004","volume":"45","author":"ZA Ratan","year":"2021","unstructured":"Ratan ZA, Haidere MF, Hong YH, Park SH, Lee JO, Lee J, et al. Pharmacological potential of ginseng and its major component ginsenosides. J Ginseng Res. 2021;45:199\u2013210.","journal-title":"J Ginseng Res"},{"key":"1416_CR8","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1039\/D0FO01896A","volume":"12","author":"M Guo","year":"2021","unstructured":"Guo M, Shao S, Wang D, Zhao D, Wang M. Recent progress in polysaccharides from Panax ginseng CA Meyer. Food Funct. 2021;12:494\u2013518.","journal-title":"Food Funct"},{"key":"1416_CR9","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.jbiotec.2024.06.018","volume":"392","author":"Y Hu","year":"2024","unstructured":"Hu Y, Li Y, Cao Y, Shen Y, Zou X, Liu J, et al. Advancements in enzymatic biotransformation and bioactivities of rare ginsenosides: a review. J Biotechnol. 2024;392:78\u201389.","journal-title":"J Biotechnol"},{"issue":"6","key":"1416_CR10","volume":"2025","author":"H Shen","year":"2020","unstructured":"Shen H, Fu J, Liu J, Zou T, Wang K, Zhang XJ, et al. Ginsenoside Rk2 alleviates hepatic ischemia\/reperfusion injury by enhancing AKT membrane translocation and activation. MedComm. 2020;2025(6):e70047.","journal-title":"MedComm"},{"key":"1416_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jare.2025.09.051","author":"KH Wang","year":"2025","unstructured":"Wang KH, Liu JY, Ma LJ, Zhang FX, Wan JB. The rise of dehydrated ginsenosides: phytochemistry and pharmacology. J Adv Res. 2025. https:\/\/doi.org\/10.1016\/j.jare.2025.09.051.","journal-title":"J Adv Res"},{"key":"1416_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.foodchem.2021.130965","volume":"369","author":"LJ Ma","year":"2022","unstructured":"Ma LJ, Ma N, Cao JL, Wan JB. Characterizing the influence of different drying methods on chemical components of Panax notoginseng leaves by heart-cutting two-dimensional liquid chromatography coupled to Orbitrap high-resolution mass spectrometry. Food Chem. 2022;369:130965.","journal-title":"Food Chem"},{"key":"1416_CR13","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1016\/j.apsb.2020.12.017","volume":"11","author":"MQ Hou","year":"2021","unstructured":"Hou MQ, Wang RF, Zhao SJ, Wang ZT. Ginsenosides in genus and their biosynthesis. Acta Pharm Sin B. 2021;11:1813\u201334.","journal-title":"Acta Pharm Sin B"},{"key":"1416_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.indcrop.2025.120636","volume":"226","author":"LJ Ma","year":"2025","unstructured":"Ma LJ, Liu JY, Fu WY, Bi HC, Yuan D, Wan JB. \u03b2-glucosidase mediates ginsenoside hydrolysis in the leaves of Panax species. Ind Crops Prod. 2025;226:120636.","journal-title":"Ind Crops Prod"},{"key":"1416_CR15","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.jare.2024.01.003","volume":"66","author":"W Fan","year":"2024","unstructured":"Fan W, Fan L, Wang Z, Mei Y, Liu L, Li L, et al. Rare ginsenosides: a unique perspective of ginseng research. J Adv Res. 2024;66:303\u201328.","journal-title":"J Adv Res"},{"key":"1416_CR16","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1142\/S0192415X21500579","volume":"49","author":"JH Zhang","year":"2021","unstructured":"Zhang JH, Yang HZ, Su H, Song J, Bai Y, Deng L, et al. Berberine and ginsenoside Rb1 ameliorate depression-like behavior in diabetic rats. Am J Chin Med. 2021;49:1195\u2013213.","journal-title":"Am J Chin Med"},{"key":"1416_CR17","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.jep.2017.04.009","volume":"204","author":"GL Wang","year":"2017","unstructured":"Wang GL, He ZM, Zhu HY, Gao YG, Zhao Y, Yang H, et al. Involvement of serotonergic, noradrenergic and dopaminergic systems in the antidepressant-like effect of ginsenoside Rb1, a major active ingredient of CA Meyer. J Ethnopharmacol. 2017;204:118\u201324.","journal-title":"J Ethnopharmacol"},{"key":"1416_CR18","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.680903","volume":"12","author":"N Jiang","year":"2021","unstructured":"Jiang N, Huang H, Zhang YW, Lv JW, Wang Q, He QH, et al. Ginsenoside Rb1 produces antidepressant-like effects in a chronic social defeat stress model of depression through the BDNF-Trkb signaling pathway. Front Pharmacol. 2021;12:680903.","journal-title":"Front Pharmacol"},{"key":"1416_CR19","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1016\/j.biopha.2017.05.119","volume":"92","author":"Z Mou","year":"2017","unstructured":"Mou Z, Huang Q, Chu SF, Zhang MJ, Hu JF, Chen NH, et al. Antidepressive effects of ginsenoside Rg1 via regulation of HPA and HPG axis. Biomed Pharmacother. 2017;92:962\u201371.","journal-title":"Biomed Pharmacother"},{"key":"1416_CR20","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.jgr.2021.04.003","volume":"46","author":"X Xu","year":"2022","unstructured":"Xu X, Lu YN, Cheng JH, Lan HW, Lu JM, Jin GN, et al. Ginsenoside Rh2 reduces depression in offspring of mice with maternal Toxoplasma infection during pregnancy by inhibiting microglial activation via the HMGB1\/TLR4\/NF-kappaB signaling pathway. J Ginseng Res. 2022;46:62\u201370.","journal-title":"J Ginseng Res"},{"key":"1416_CR21","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2022.868833","volume":"9","author":"N Jiang","year":"2022","unstructured":"Jiang N, Zhang Y, Yao C, Huang H, Wang Q, Huang S, et al. Ginsenosides Rb1 attenuates chronic social defeat stress-induced depressive behavior via regulation of SIRT1-NLRP3\/Nrf2 pathways. Front Nutr. 2022;9:868833.","journal-title":"Front Nutr"},{"key":"1416_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020.117669","volume":"252","author":"N Jiang","year":"2020","unstructured":"Jiang N, Lv J, Wang H, Huang H, Wang Q, Lu C, et al. Ginsenoside Rg1 ameliorates chronic social defeat stress-induced depressive-like behaviors and hippocampal neuroinflammation. Life Sci. 2020;252:117669.","journal-title":"Life Sci"},{"key":"1416_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/srep19406","volume":"6","author":"X Zheng","year":"2016","unstructured":"Zheng X, Ma S, Kang A, Wu M, Wang L, Wang Q, et al. Chemical dampening of Ly6C(hi) monocytes in the periphery produces anti-depressant effects in mice. Sci Rep. 2016;6:19406.","journal-title":"Sci Rep"},{"key":"1416_CR24","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/s11418-016-1066-1","volume":"71","author":"Z You","year":"2017","unstructured":"You Z, Yao Q, Shen J, Gu Z, Xu H, Wu Z, et al. Antidepressant-like effects of ginsenoside Rg3 in mice via activation of the hippocampal BDNF signaling cascade. J Nat Med. 2017;71:367\u201379.","journal-title":"J Nat Med"},{"key":"1416_CR25","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.neulet.2017.02.071","volume":"645","author":"D Xu","year":"2017","unstructured":"Xu D, Wang C, Zhao W, Gao S, Cui Z. Antidepressant-like effects of ginsenoside Rg5 in mice: involving of hippocampus BDNF signaling pathway. Neurosci Lett. 2017;645:97\u2013105.","journal-title":"Neurosci Lett"},{"key":"1416_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2020.135561","volume":"744","author":"Y Guo","year":"2021","unstructured":"Guo Y, Xie J, Zhang L, Yang L, Ma J, Bai Y, et al. Ginsenoside Rb1 exerts antidepressant-like effects via suppression inflammation and activation of AKT pathway. Neurosci Lett. 2021;744:135561.","journal-title":"Neurosci Lett"},{"key":"1416_CR27","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1007\/s11011-024-01392-x","volume":"39","author":"CF Li","year":"2024","unstructured":"Li CF, Zhang QP, Cheng J, Xu GH, Zhu JX, Yi LT. Role of ginsenoside Rb1 in attenuating depression-like symptoms through astrocytic and microglial complement C3 pathway. Metab Brain Dis. 2024;39:1039\u201350.","journal-title":"Metab Brain Dis"},{"key":"1416_CR28","doi-asserted-by":"publisher","first-page":"2855","DOI":"10.1007\/s12035-022-02740-7","volume":"59","author":"J Li","year":"2022","unstructured":"Li J, Gao W, Zhao Z, Li Y, Yang L, Wei W, et al. Ginsenoside Rg1 reduced microglial activation and mitochondrial dysfunction to alleviate depression-like behaviour via the GAS5\/EZH2\/SOCS3\/NRF2 axis. Mol Neurobiol. 2022;59:2855\u201373.","journal-title":"Mol Neurobiol"},{"key":"1416_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-99587-4","volume":"15","author":"L Gao","year":"2025","unstructured":"Gao L, Wang J, Liu X, Wu L, Ding R, Han X, et al. Rinsenoside Rg1 and its involvement in Hippo-YAP signaling pathway alleviating symptoms of depressive-like behavior. Sci Rep. 2025;15:14441.","journal-title":"Sci Rep"},{"key":"1416_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2025.119960","volume":"349","author":"H Chu","year":"2025","unstructured":"Chu H, Sun N, Tang Q, Yu X, Li L, Chang H. Deciphering the polypharmacology of Dingzhi Xiaowan against comorbid depression: integrated metabolomics of brain tissue and network pharmacology analysis in chronic restraint stress (CRS)-LPS model. J Ethnopharmacol. 2025;349:119960.","journal-title":"J Ethnopharmacol"},{"key":"1416_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-021-02185-0","volume":"18","author":"L Zhang","year":"2021","unstructured":"Zhang L, Tang M, Xie X, Zhao Q, Hu N, He H, et al. Ginsenoside Rb1 induces a pro-neurogenic microglial phenotype via PPARgamma activation in male mice exposed to chronic mild stress. J Neuroinflammation. 2021;18:171.","journal-title":"J Neuroinflammation"},{"key":"1416_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2023.176120","volume":"960","author":"H He","year":"2023","unstructured":"He H, Xie X, Kang X, Zhang J, Wang L, Hu N, et al. Ginsenoside Rg1 ameliorates depressive-like behavior by inhibiting NLRP3 inflammasome activation in mice exposed to chronic stress. Eur J Pharmacol. 2023;960:176120.","journal-title":"Eur J Pharmacol"},{"key":"1416_CR33","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.jgr.2024.12.002","volume":"49","author":"KK Jia","year":"2025","unstructured":"Jia KK, Pan SM, Wu WY, Sun YM, Zhang QY. Ginsenoside Rg1 exerts antidepressant effect by regulating hepatic kynurenine metabolism through promoting the interaction between HNF4\u03b1 and PGC1\u03b1. J Ginseng Res. 2025;49:179\u201388.","journal-title":"J Ginseng Res"},{"key":"1416_CR34","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.brainresbull.2017.08.009","volume":"134","author":"Y Ren","year":"2017","unstructured":"Ren Y, Wang JL, Zhang X, Wang H, Ye Y, Song L, et al. Antidepressant-like effects of ginsenoside Rg2 in a chronic mild stress model of depression. Brain Res Bull. 2017;134:211\u20139.","journal-title":"Brain Res Bull"},{"key":"1416_CR35","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.jphs.2017.03.007","volume":"134","author":"H Zhang","year":"2017","unstructured":"Zhang H, Zhou Z, Chen Z, Zhong Z, Li Z. Ginsenoside Rg3 exerts anti-depressive effect on an NMDA-treated cell model and a chronic mild stress animal model. J Pharmacol Sci. 2017;134:45\u201354.","journal-title":"J Pharmacol Sci"},{"key":"1416_CR36","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.709019","volume":"12","author":"H Wang","year":"2021","unstructured":"Wang H, Yang Y, Yang S, Ren S, Feng J, Liu Y, et al. Ginsenoside Rg1 ameliorates neuroinflammation via suppression of Connexin43 ubiquitination to attenuate depression. Front Pharmacol. 2021;12:709019.","journal-title":"Front Pharmacol"},{"key":"1416_CR37","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1038\/s41401-025-01515-9","volume":"46","author":"HQ Wang","year":"2025","unstructured":"Wang HQ, Zheng RF, Ai QD, Yang SW, Yang XY, Chen AP, et al. Ginsenoside Rg1 alleviates chronic stress-induced depression in rats by targeting Cx43-YAP axis. Acta Pharmacol Sin. 2025;46:1877\u201391.","journal-title":"Acta Pharmacol Sin"},{"key":"1416_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2020.173309","volume":"882","author":"YX Lou","year":"2020","unstructured":"Lou YX, Wang ZZ, Xia CY, Mou Z, Ren Q, Liu DD, et al. The protective effect of ginsenoside Rg1 on depression may benefit from the gap junction function in hippocampal astrocytes. Eur J Pharmacol. 2020;882:173309.","journal-title":"Eur J Pharmacol"},{"key":"1416_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2020.108041","volume":"170","author":"CY Xia","year":"2020","unstructured":"Xia CY, Wang ZZ, Wang HQ, Ren SY, Lou YX, Jin C, et al. Connexin 43: a novel ginsenoside Rg1-sensitive target in a rat model of depression. Neuropharmacology. 2020;170:108041.","journal-title":"Neuropharmacology"},{"key":"1416_CR40","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.pnpbp.2016.09.006","volume":"75","author":"C Jin","year":"2017","unstructured":"Jin C, Wang ZZ, Zhou H, Lou YX, Chen J, Zuo W, et al. Ginsenoside Rg1-induced antidepressant effects involve the protection of astrocyte gap junctions within the prefrontal cortex. Prog Neuropsychopharmacol Biol Psychiatry. 2017;75:183\u201391.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"1416_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-26146-5","volume":"8","author":"JN Xu","year":"2018","unstructured":"Xu JN, Chen LF, Su J, Liu ZL, Chen J, Lin QF, et al. The anxiolytic-like effects of ginsenoside Rg3 on chronic unpredictable stress in rats. Sci Rep. 2018;8:7741.","journal-title":"Sci Rep"},{"key":"1416_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2024.156186","volume":"135","author":"S Yu","year":"2024","unstructured":"Yu S, Yin Z, Ling M, Chen Z, Zhang Y, Pan Y, et al. Ginsenoside Rg1 enriches gut microbial indole-3-acetic acid to alleviate depression-like behavior in mice via oxytocin signaling. Phytomedicine. 2024;135:156186.","journal-title":"Phytomedicine"},{"key":"1416_CR43","doi-asserted-by":"publisher","first-page":"19838","DOI":"10.1021\/acs.jafc.4c04394","volume":"72","author":"H Chen","year":"2024","unstructured":"Chen H, Dong M, He H, Piao X, Han X, Li R, et al. Ginsenoside Re prevents depression-like behaviors via inhibition of inflammation, oxidative stress, and activating BDNF\/TrkB\/ERK\/CREB signaling: an in vivo and in vitro study. J Agric Food Chem. 2024;72:19838\u201351.","journal-title":"J Agric Food Chem"},{"key":"1416_CR44","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25179673","volume":"25","author":"D Kwon","year":"2024","unstructured":"Kwon D, Kim Y, Cho SH. Antidepressant effects of ginsenoside Rc on L-Alpha-Aminoadipic Acid-induced astrocytic ablation and neuroinflammation in mice. Int J Mol Sci. 2024;25:9673.","journal-title":"Int J Mol Sci"},{"key":"1416_CR45","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/j.jgr.2019.08.005","volume":"44","author":"Y Kim","year":"2020","unstructured":"Kim Y, Lee HY, Choi YJ, Cho SH. Antidepressant effects of ginsenoside Rf on behavioral change in the glial degeneration model of depression by reversing glial loss. J Ginseng Res. 2020;44:603\u201310.","journal-title":"J Ginseng Res"},{"key":"1416_CR46","doi-asserted-by":"publisher","first-page":"7222","DOI":"10.1039\/D3FO00496A","volume":"14","author":"W Wang","year":"2023","unstructured":"Wang W, Wang L, Wang L, Li Y, Lan T, Wang C, et al. Ginsenoside-Rg1 synergized with voluntary running exercise protects against glial activation and dysregulation of neuronal plasticity in depression. Food Funct. 2023;14:7222\u201339.","journal-title":"Food Funct"},{"key":"1416_CR47","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1007\/s12035-020-02213-9","volume":"58","author":"Z Zhang","year":"2021","unstructured":"Zhang Z, Song Z, Shen F, Xie P, Wang J, Zhu A-s, et al. Ginsenoside Rg1 prevents PTSD-like behaviors in mice through promoting synaptic proteins, reducing Kir4. 1 and TNF-\u03b1 in the hippocampus. Mol Neurobiol. 2021;58:1550\u201363.","journal-title":"Mol Neurobiol"},{"key":"1416_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2021.114655","volume":"282","author":"W Liang","year":"2022","unstructured":"Liang W, Liu Y, Zhou K, Jian P, Zhang Q, Chang Z, et al. Ginsenoside Rb1 prevents lipopolysaccharide-induced depressive-like behavior by inhibiting inflammation and neural dysfunction and F2 elicits a novel antidepressant-like effect: a metabolite-based network pharmacology study. J Ethnopharmacol. 2022;282:114655.","journal-title":"J Ethnopharmacol"},{"issue":"3","key":"1416_CR49","first-page":"526","volume":"2023","author":"Z Sahin","year":"2021","unstructured":"Sahin Z. Assessment of commonly used tests in experimental depression studies according to behavioral patterns of rodents. Med Rev. 2021;2023(3):526\u201331.","journal-title":"Med Rev"},{"key":"1416_CR50","volume":"97","author":"R Yankelevitch-Yahav","year":"2015","unstructured":"Yankelevitch-Yahav R, Franko M, Huly A, Doron R. The forced swim test as a model of depressive-like behavior. J Vis Exp. 2015;97:52587.","journal-title":"J Vis Exp"},{"key":"1416_CR51","doi-asserted-by":"publisher","first-page":"191","DOI":"10.3758\/s13415-024-01171-2","volume":"24","author":"S Gencturk","year":"2024","unstructured":"Gencturk S, Unal G. Rodent tests of depression and anxiety: construct validity and translational relevance. Cogn Affect Behav Neurosci. 2024;24:191\u2013224.","journal-title":"Cogn Affect Behav Neurosci"},{"key":"1416_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.beproc.2022.104670","volume":"200","author":"B Acikgoz","year":"2022","unstructured":"Acikgoz B, Dalkiran B, Dayi A. An overview of the currency and usefulness of behavioral tests used from past to present to assess anxiety, social behavior and depression in rats and mice. Behav Processes. 2022;200:104670.","journal-title":"Behav Processes"},{"key":"1416_CR53","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.jgr.2021.03.005","volume":"46","author":"G Wang","year":"2022","unstructured":"Wang G, An T, Lei C, Zhu X, Yang L, Zhang L, et al. Antidepressant-like effect of ginsenoside Rb1 on potentiating synaptic plasticity via the miR-134-mediated BDNF signaling pathway in a mouse model of chronic stress-induced depression. J Ginseng Res. 2022;46:376\u201386.","journal-title":"J Ginseng Res"},{"key":"1416_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2025.115071","volume":"162","author":"H Chen","year":"2025","unstructured":"Chen H, Piao J, Geng Z, Han X, Li R, Cui R, et al. Ginsenoside Rd alleviates LPS-induced neuroinflammation and depressive-like behaviors via regulating TLR4-PI3K-NF-kappaB-JMJD3 signaling. Int Immunopharmacol. 2025;162:115071.","journal-title":"Int Immunopharmacol"},{"key":"1416_CR55","doi-asserted-by":"publisher","first-page":"10934","DOI":"10.1021\/acs.jafc.4c09773","volume":"73","author":"S Liu","year":"2025","unstructured":"Liu S, Zhang Y, Zhou H, Ma Y, Huang F, Lei T, et al. Ginsenoside Re inhibits NLRP3 inflammasome activation in depressive mice by promoting PINK1-mediated mitophagy. J Agric Food Chem. 2025;73:10934\u201346.","journal-title":"J Agric Food Chem"},{"key":"1416_CR56","doi-asserted-by":"publisher","DOI":"10.1002\/brb3.2705","volume":"12","author":"LS Shi","year":"2022","unstructured":"Shi LS, Ji CH, Liu Y, Gu JH, Tang WQ, Zhang W, et al. Ginsenoside Rh2 administration produces crucial antidepressant-like effects in a CUMS-induced mice model of depression. Brain Behav. 2022;12:e2705.","journal-title":"Brain Behav"},{"key":"1416_CR57","doi-asserted-by":"publisher","DOI":"10.1016\/j.foodchem.2022.134639","volume":"404","author":"J Shao","year":"2023","unstructured":"Shao J, Ma X, Qu L, Ma P, Huang R, Fan D. Ginsenoside Rh4 remodels the periphery microenvironment by targeting the brain-gut axis to alleviate depression-like behaviors. Food Chem. 2023;404:134639.","journal-title":"Food Chem"},{"key":"1416_CR58","doi-asserted-by":"publisher","first-page":"7100","DOI":"10.1021\/acs.jafc.3c07599","volume":"72","author":"J Shao","year":"2024","unstructured":"Shao J, Qu L, Liu Y, Zhang J, Liu Y, Deng J, et al. Ginsenoside Rk3 regulates tryptophan metabolism along the brain-gut axis by targeting tryptophan hydroxylase and remodeling the intestinal microenvironment to alleviate depressive-like behavior in mice. J Agric Food Chem. 2024;72:7100\u201320.","journal-title":"J Agric Food Chem"},{"key":"1416_CR59","doi-asserted-by":"publisher","DOI":"10.3390\/molecules29215085","volume":"29","author":"P Guo","year":"2024","unstructured":"Guo P, Wang Z, Sun L, He Z, Li J, Geng J, et al. 20 (S)-Protopanaxadiol alleviates DRP1-mediated mitochondrial dysfunction in a depressive model in vitro and in vivo via the SIRT1\/PGC-1alpha signaling pathway. Molecules. 2024;29:5085.","journal-title":"Molecules"},{"key":"1416_CR60","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1002\/ddr.21847","volume":"83","author":"Q Zhan","year":"2022","unstructured":"Zhan Q, Wu Y, Liu L. Effects of notoginsenoside R1 on attenuating depressive behavior induced by chronic stress in rats through induction of PI3K\/AKT\/NF-\u03baB pathway. Drug Dev Res. 2022;83:97\u2013104.","journal-title":"Drug Dev Res"},{"key":"1416_CR61","doi-asserted-by":"publisher","DOI":"10.3390\/ijms252312606","volume":"25","author":"W Chen","year":"2024","unstructured":"Chen W, Guo P, Su L, Guo X, Shi M, Geng J, et al. Combining network pharmacology and transcriptomic strategies to explore the pharmacological mechanism of total ginsenoside ginseng root and its impact on antidepressant effects. Int J Mol Sci. 2024;25:12606.","journal-title":"Int J Mol Sci"},{"key":"1416_CR62","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.590457","volume":"11","author":"L Zhao","year":"2020","unstructured":"Zhao L, Guo R, Cao N, Lin Y, Yang W, Pei S, et al. An integrative pharmacology-based pattern to uncover the pharmacological mechanism of Ginsenoside H dripping pills in the treatment of depression. Front Pharmacol. 2020;11:590457.","journal-title":"Front Pharmacol"},{"key":"1416_CR63","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12906-023-03970-5","volume":"23","author":"MM Xu","year":"2023","unstructured":"Xu MM, Zhai WJW, Zhang Y, Pan JH, Li J, Huang SJ. Kaixin Jieyu Granule attenuates neuroinflammation-induced depressive-like behavior through TLR4\/PI3K\/AKT\/FOXO1 pathway: a study of network pharmacology and experimental validation. BMC Complement Med Ther. 2023;23:1\u201318.","journal-title":"BMC Complement Med Ther"},{"key":"1416_CR64","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1176\/appi.ajp.2020.20030305","volume":"177","author":"NH Kalin","year":"2020","unstructured":"Kalin NH. The critical relationship between anxiety and depression. Am J Psychiatry. 2020;177:365\u20137.","journal-title":"Am J Psychiatry"},{"key":"1416_CR65","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/978-1-4939-8994-2_9","volume":"1916","author":"AK Kraeuter","year":"2019","unstructured":"Kraeuter AK, Guest PC, Sarnyai Z. The open field test for measuring locomotor activity and anxiety-like behavior. Methods Mol Biol. 2019;1916:99\u2013103.","journal-title":"Methods Mol Biol"},{"key":"1416_CR66","doi-asserted-by":"publisher","DOI":"10.3389\/fnbeh.2023.1182661","volume":"17","author":"L Gaspar","year":"2023","unstructured":"Gaspar L, Bartman S, Coppotelli G, Ross JM. Effect of apparatus characteristics on anxiety-like behavior in young adult and old mice of both sexes assessed by the elevated plus maze assay. Front Behav Neurosci. 2023;17:1182661.","journal-title":"Front Behav Neurosci"},{"key":"1416_CR67","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.neulet.2017.08.019","volume":"658","author":"A Blasco-Serra","year":"2017","unstructured":"Blasco-Serra A, Gonzalez-Soler EM, Cervera-Ferri A, Teruel-Marti V, Valverde-Navarro AA. A standardization of the novelty-suppressed feeding test protocol in rats. Neurosci Lett. 2017;658:73\u20138.","journal-title":"Neurosci Lett"},{"key":"1416_CR68","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2023.155083","volume":"121","author":"Y Li","year":"2023","unstructured":"Li Y, Li J, Yang L, Ren F, Dong K, Zhao Z, et al. Ginsenoside Rb1 protects hippocampal neurons in depressed rats based on mitophagy-regulated astrocytic pyroptosis. Phytomedicine. 2023;121:155083.","journal-title":"Phytomedicine"},{"key":"1416_CR69","doi-asserted-by":"publisher","first-page":"843","DOI":"10.2147\/DDDT.S351421","volume":"16","author":"Y Li","year":"2022","unstructured":"Li Y, Wang ML, Zhang B, Fan XX, Tang Q, Yu X, et al. Antidepressant-like effect and mechanism of Ginsenoside Rd on rodent models of depression. Drug Des Devel Ther. 2022;16:843\u201361.","journal-title":"Drug Des Devel Ther"},{"key":"1416_CR70","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1097\/WNR.0000000000001302","volume":"30","author":"YQ Zhang","year":"2019","unstructured":"Zhang YQ, Wang XB, Xue RR, Gao XX, Li W. Ginsenoside Rg1 attenuates chronic unpredictable mild stress-induced depressive-like effect via regulating NF-kappaB\/NLRP3 pathway in rats. NeuroReport. 2019;30:893\u2013900.","journal-title":"NeuroReport"},{"key":"1416_CR71","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1007\/s11655-025-3935-5","volume":"32","author":"L Yao","year":"2026","unstructured":"Yao L, Chen C, Jing R, Wang CC, Wang YB, Li X, et al. Kai-Xin-San has antidepressant-like effect in tricyclic antidepressant treatment resistant animal model by rebalancing Tryptophan metabolism. Chin J Integr Med. 2026;32:322\u201331.","journal-title":"Chin J Integr Med"},{"key":"1416_CR72","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2022.e12182","author":"TT Li","year":"2022","unstructured":"Li TT, Li XT, Zhang JS, Yu ZH, Gong F, Wang J, et al. Chemical component analysis of the traditional Chinese medicine Guipi Tang and its effects on major depressive disorder at molecular level. Heliyon. 2022;8:e12182","journal-title":"Heliyon"},{"key":"1416_CR73","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2025.156997","volume":"145","author":"R Lu","year":"2025","unstructured":"Lu R, Yang J, Fan R, Li H, Liu Y, Wang T, et al. Prophylactic administration of Xuesaitong soft capsule ameliorating depression-like behaviors in rats after ischemic stroke by modulating metabolic disturbance. Phytomedicine. 2025;145:156997.","journal-title":"Phytomedicine"},{"key":"1416_CR74","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2023.116468","volume":"313","author":"XX Liao","year":"2023","unstructured":"Liao XX, Hu K, Xie XH, Wen YL, Wang R, Hu ZW, et al. Banxia Xiexin decoction alleviates AS co-depression disease by regulating the gut microbiome-lipid metabolic axis. J Ethnopharmacol. 2023;313:116468.","journal-title":"J Ethnopharmacol"},{"key":"1416_CR75","doi-asserted-by":"publisher","DOI":"10.3390\/nu12040901","volume":"12","author":"SK Han","year":"2020","unstructured":"Han SK, Joo MK, Kim JK, Jeung W, Kang H, Kim DH. Bifidobacteria-fermented Red Ginseng and its constituents Ginsenoside Rd and Protopanaxatriol alleviate anxiety\/depression in mice by the amelioration of gut dysbiosis. Nutrients. 2020;12:901.","journal-title":"Nutrients"},{"key":"1416_CR76","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.jad.2024.01.023","volume":"349","author":"TY Zhao","year":"2024","unstructured":"Zhao TY, Liu T, Wang L, Xie KQ, Tang H, Tang MM. Dysfunction of neurotransmitter metabolism is associated with the severity of depression in first-diagnosed, drug-naive depressed patients. J Affect Disord. 2024;349:332\u201341.","journal-title":"J Affect Disord"},{"key":"1416_CR77","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-018-0183-x","volume":"8","author":"JX Pan","year":"2018","unstructured":"Pan JX, Xia JJ, Deng FL, Liang WW, Wu J, Yin BM, et al. Diagnosis of major depressive disorder based on changes in multiple plasma neurotransmitters: a targeted metabolomics study. Transl Psychiatry. 2018;8:130.","journal-title":"Transl Psychiatry"},{"key":"1416_CR78","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2021.637863","volume":"12","author":"A Sarawagi","year":"2021","unstructured":"Sarawagi A, Soni ND, Patel AB. Glutamate and GABA homeostasis and neurometabolism in major depressive disorder. Front Psychiatry. 2021;12:637863.","journal-title":"Front Psychiatry"},{"key":"1416_CR79","doi-asserted-by":"publisher","first-page":"6861","DOI":"10.1021\/acs.jafc.7b02386","volume":"65","author":"A Kang","year":"2017","unstructured":"Kang A, Xie T, Zhu D, Shan J, Di L, Zheng X. Suppressive effect of Ginsenoside Rg3 against Lipopolysaccharide-induced depression-like behavior and neuroinflammation in mice. J Agric Food Chem. 2017;65:6861\u20139.","journal-title":"J Agric Food Chem"},{"key":"1416_CR80","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2020.00381","volume":"11","author":"XJ Shao","year":"2020","unstructured":"Shao XJ, Zhu G. Associations among monoamine neurotransmitter pathways, personality traits, and major depressive disorder. Front Psychiatry. 2020;11:381.","journal-title":"Front Psychiatry"},{"key":"1416_CR81","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2020.110139","volume":"105","author":"GN Erjavec","year":"2021","unstructured":"Erjavec GN, Sagud M, Perkovic MN, Strac DS, Konjevod M, Tudor L, et al. Depression: biological markers and treatment. Prog Neuro-Psychopharmacol Biol Psychiatry. 2021;105:110139.","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"key":"1416_CR82","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.pbb.2015.10.018","volume":"140","author":"H Zhang","year":"2016","unstructured":"Zhang H, Li Z, Zhou Z, Yang H, Zhong Z, Lou C. Antidepressant-like effects of ginsenosides: a comparison of ginsenoside Rb3 and its four deglycosylated derivatives, Rg3, Rh2, compound K, and 20(S)-protopanaxadiol in mice models of despair. Pharmacol Biochem Behav. 2016;140:17\u201326.","journal-title":"Pharmacol Biochem Behav"},{"key":"1416_CR83","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.brainres.2018.05.035","volume":"1699","author":"GL Wang","year":"2018","unstructured":"Wang GL, Wang YP, Zheng JY, Zhang LX. Monoaminergic and aminoacidergic receptors are involved in the antidepressant-like effect of ginsenoside Rb1 in mouse hippocampus (CA3) and prefrontal cortex. Brain Res. 2018;1699:44\u201353.","journal-title":"Brain Res"},{"key":"1416_CR84","doi-asserted-by":"publisher","first-page":"870","DOI":"10.3390\/molecules24050870","volume":"24","author":"LX Chen","year":"2019","unstructured":"Chen LX, Qi Z, Shao ZJ, Li SS, Qi YL, Gao K, et al. Study on antidepressant activity of pseudo-ginsenoside HQ on depression-like behavior in mice. Molecules. 2019;24:870.","journal-title":"Molecules"},{"key":"1416_CR85","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2021.105761","volume":"171","author":"YT Wang","year":"2021","unstructured":"Wang YT, Wang XL, Feng ST, Chen NH, Wang ZZ, Zhang Y. Novel rapid-acting glutamatergic modulators: targeting the synaptic plasticity in depression. Pharmacol Res. 2021;171:105761.","journal-title":"Pharmacol Res"},{"key":"1416_CR86","doi-asserted-by":"publisher","first-page":"917","DOI":"10.3390\/nu14050917","volume":"14","author":"T McGrath","year":"2022","unstructured":"McGrath T, Baskerville R, Rogero M, Castell L. Emerging evidence for the widespread role of glutamatergic dysfunction in neuropsychiatric diseases. Nutrients. 2022;14:917.","journal-title":"Nutrients"},{"key":"1416_CR87","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1111\/jnc.15811","volume":"166","author":"JV Andersen","year":"2023","unstructured":"Andersen JV, Schousboe A. Milestone review: metabolic dynamics of glutamate and GABA mediated neurotransmission - The essential roles of astrocytes. J Neurochem. 2023;166:109\u201337.","journal-title":"J Neurochem"},{"key":"1416_CR88","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1042\/EBC20220208","volume":"67","author":"JV Andersen","year":"2023","unstructured":"Andersen JV, Schousboe A, Wellendorph P. Astrocytes regulate inhibitory neurotransmission through GABA uptake, metabolism, and recycling. Essays Biochem. 2023;67:77\u201391.","journal-title":"Essays Biochem"},{"key":"1416_CR89","doi-asserted-by":"publisher","first-page":"4566","DOI":"10.1002\/slct.202100773","volume":"6","author":"S Raj Rai","year":"2021","unstructured":"Raj Rai S, Bhattacharyya C, Sarkar A, Chakraborty S, Sircar E, Dutta S, et al. Glutathione: role in oxidative\/nitrosative stress, antioxidant defense, and treatments. ChemistrySelect. 2021;6:4566\u201390.","journal-title":"ChemistrySelect"},{"key":"1416_CR90","doi-asserted-by":"publisher","DOI":"10.1016\/j.yfrne.2019.100800","volume":"56","author":"M Majd","year":"2020","unstructured":"Majd M, Saunders EFH, Engeland CG. Inflammation and the dimensions of depression: a review. Front Neuroendocrinol. 2020;56:100800.","journal-title":"Front Neuroendocrinol"},{"key":"1416_CR91","doi-asserted-by":"publisher","first-page":"578","DOI":"10.3390\/ijms24010578","volume":"24","author":"S Harsanyi","year":"2022","unstructured":"Harsanyi S, Kupcova I, Danisovic L, Klein M. Selected biomarkers of depression: what are the effects of cytokines and inflammation? Int J Mol Sci. 2022;24:578.","journal-title":"Int J Mol Sci"},{"key":"1416_CR92","doi-asserted-by":"publisher","first-page":"503","DOI":"10.3988\/jcn.2021.17.4.503","volume":"17","author":"KM Han","year":"2021","unstructured":"Han KM, Ham BJ. How inflammation affects the brain in depression: a review of functional and structural MRI studies. J Clin Neurol. 2021;17:503\u201315.","journal-title":"J Clin Neurol"},{"key":"1416_CR93","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.euroneuro.2021.09.006","volume":"54","author":"J Kofod","year":"2022","unstructured":"Kofod J, Elfving B, Nielsen EH, Mors O, K\u00f6hler-Forsberg O. Depression and inflammation: correlation between changes in inflammatory markers with antidepressant response and long-term prognosis. Eur Neuropsychopharmacol. 2022;54:116\u201325.","journal-title":"Eur Neuropsychopharmacol"},{"key":"1416_CR94","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/S1359-6101(98)00024-0","volume":"10","author":"A Meager","year":"1999","unstructured":"Meager A. Cytokine regulation of cellular adhesion molecule expression in inflammation. Cytokine Growth Factor Rev. 1999;10:27\u201339.","journal-title":"Cytokine Growth Factor Rev"},{"key":"1416_CR95","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1097\/AIA.0b013e318034194e","volume":"45","author":"JM Zhang","year":"2007","unstructured":"Zhang JM, An J. Cytokines, inflammation, and pain. Int Anesthesiol Clin. 2007;45:27\u201337.","journal-title":"Int Anesthesiol Clin"},{"key":"1416_CR96","first-page":"136","volume":"3","author":"WY Wang","year":"2015","unstructured":"Wang WY, Tan MS, Yu JT, Tan L. Role of pro-inflammatory cytokines released from microglia in Alzheimer\u2019s disease. Ann Transl Med. 2015;3:136.","journal-title":"Ann Transl Med"},{"key":"1416_CR97","doi-asserted-by":"publisher","first-page":"3949","DOI":"10.3390\/ijms21113949","volume":"21","author":"AC Betzler","year":"2020","unstructured":"Betzler AC, Theodoraki MN, Schuler PJ, Doscher J, Laban S, Hoffmann TK, et al. NF-kappaB and its role in checkpoint control. Int J Mol Sci. 2020;21:3949.","journal-title":"Int J Mol Sci"},{"key":"1416_CR98","doi-asserted-by":"publisher","DOI":"10.1016\/j.actatropica.2020.105458","volume":"207","author":"M Akhtar","year":"2020","unstructured":"Akhtar M, Guo S, Guo YF, Zahoor A, Shaukat A, Chen Y, et al. Upregulated-gene expression of pro-inflammatory cytokines (TNF-alpha, IL-1beta and IL-6) via TLRs following NF-kappaB and MAPKs in bovine mastitis. Acta Trop. 2020;207:105458.","journal-title":"Acta Trop"},{"key":"1416_CR99","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2021.108255","volume":"101","author":"A Attiq","year":"2021","unstructured":"Attiq A, Yao LJ, Afzal S, Khan MA. The triumvirate of NF-kappaB, inflammation and cytokine storm in COVID-19. Int Immunopharmacol. 2021;101:108255.","journal-title":"Int Immunopharmacol"},{"key":"1416_CR100","doi-asserted-by":"publisher","first-page":"918","DOI":"10.2174\/1570159X18666200207120949","volume":"18","author":"S Singh","year":"2020","unstructured":"Singh S, Singh TG. Role of nuclear factor kappa B (NF-kappaB) signalling in neurodegenerative diseases: an mechanistic approach. Curr Neuropharmacol. 2020;18:918\u201335.","journal-title":"Curr Neuropharmacol"},{"key":"1416_CR101","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.cyto.2015.02.025","volume":"74","author":"D De Nardo","year":"2015","unstructured":"De Nardo D. Toll-like receptors: activation, signalling and transcriptional modulation. Cytokine. 2015;74:181\u20139.","journal-title":"Cytokine"},{"key":"1416_CR102","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2020.102617","volume":"19","author":"P Migliorini","year":"2020","unstructured":"Migliorini P, Italiani P, Pratesi F, Puxeddu I, Boraschi D. The IL-1 family cytokines and receptors in autoimmune diseases. Autoimmun Rev. 2020;19:102617.","journal-title":"Autoimmun Rev"},{"key":"1416_CR103","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.it.2011.01.003","volume":"32","author":"FL Van de Veerdonk","year":"2011","unstructured":"Van de Veerdonk FL, Netea MG, Dinarello CA, Joosten LA. Inflammasome activation and IL-1\u03b2 and IL-18 processing during infection. Trends Immunol. 2011;32:110\u20136.","journal-title":"Trends Immunol"},{"key":"1416_CR104","first-page":"4063562","volume":"2020","author":"Z Wang","year":"2020","unstructured":"Wang Z, Zhang S, Xiao Y, Zhang W, Wu S, Qin T, et al. NLRP3 inflammasome and inflammatory diseases. Oxid Med Cell Longev. 2020;2020:4063562.","journal-title":"Oxid Med Cell Longev"},{"key":"1416_CR105","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1038\/s41392-020-00312-6","volume":"5","author":"H Yu","year":"2020","unstructured":"Yu H, Lin L, Zhang Z, Zhang H, Hu H. Targeting NF-kappaB pathway for the therapy of diseases: mechanism and clinical study. Signal Transduct Target Ther. 2020;5:209.","journal-title":"Signal Transduct Target Ther"},{"key":"1416_CR106","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1523\/JNEUROSCI.2117-15.2016","volume":"36","author":"H Lian","year":"2016","unstructured":"Lian H, Litvinchuk A, Chiang ACA, Aithmitti N, Jankowsky JL, Zheng H. Astrocyte-Microglia cross talk through complement activation modulates amyloid pathology in mouse models of Alzheimer\u2019s Disease. J Neurosci. 2016;36:577\u201389.","journal-title":"J Neurosci"},{"key":"1416_CR107","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1016\/j.neuron.2018.10.031","volume":"100","author":"A Litvinchuk","year":"2018","unstructured":"Litvinchuk A, Wan YW, Swartzlander DB, Chen F, Cole A, Propson NE, et al. Complement C3aR inactivation attenuates Tau pathology and reverses an immune network deregulated in tauopathy models and Alzheimer\u2019s Disease. Neuron. 2018;100:1337-1353 e1335.","journal-title":"Neuron"},{"key":"1416_CR108","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1016\/j.bbrc.2020.07.098","volume":"530","author":"Z Li","year":"2020","unstructured":"Li Z, Zhao L, Chen J, Liu C, Li S, Hua M, et al. Ginsenoside Rk1 alleviates LPS-induced depression-like behavior in mice by promoting BDNF and suppressing the neuroinflammatory response. Biochem Biophys Res Commun. 2020;530:658\u201364.","journal-title":"Biochem Biophys Res Commun"},{"key":"1416_CR109","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/s41392-022-01257-8","volume":"7","author":"QJ Wu","year":"2022","unstructured":"Wu QJ, Zhang TN, Chen HH, Yu XF, Lv JL, Liu YY, et al. The sirtuin family in health and disease. Signal Transduct Target Ther. 2022;7:402.","journal-title":"Signal Transduct Target Ther"},{"key":"1416_CR110","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1111\/j.1600-6143.2007.01734.x","volume":"7","author":"Y Huang","year":"2007","unstructured":"Huang Y, Yin H, Han J, Huang B, Xu J, Zheng F, et al. Extracellular Hmgb1 functions as an innate immune-mediator implicated in murine cardiac allograft acute rejection. Am J Transplant. 2007;7:799\u2013808.","journal-title":"Am J Transplant"},{"key":"1416_CR111","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1186\/s12974-017-0917-3","volume":"14","author":"X Chen","year":"2017","unstructured":"Chen X, Wu S, Chen C, Xie B, Fang Z, Hu W, et al. Omega-3 polyunsaturated fatty acid supplementation attenuates microglial-induced inflammation by inhibiting the HMGB1\/TLR4\/NF-kappaB pathway following experimental traumatic brain injury. J Neuroinflammation. 2017;14:143.","journal-title":"J Neuroinflammation"},{"key":"1416_CR112","doi-asserted-by":"publisher","first-page":"106539","DOI":"10.1016\/j.intimp.2020.106539","volume":"84","author":"YN Lu","year":"2020","unstructured":"Lu YN, Zhao XD, Xu X, Piao J, Aosai F, Li YB, et al. Arctigenin exhibits hepatoprotective activity in infected host through HMGB1\/TLR4\/NF-\u03baB pathway. Int Immunopharmacol. 2020;84:106539.","journal-title":"Int Immunopharmacol"},{"key":"1416_CR113","first-page":"2325391","volume":"2020","author":"Y Li","year":"2020","unstructured":"Li Y, Wang L, Wang P, Fan C, Zhang P, Shen J, et al. Ginsenoside-Rg1 rescues stress-induced depression-like behaviors via suppression of oxidative stress and neural inflammation in rats. Oxid Med Cell Longev. 2020;2020:2325391.","journal-title":"Oxid Med Cell Longev"},{"key":"1416_CR114","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1016\/j.drudis.2020.05.001","volume":"25","author":"S Bhatt","year":"2020","unstructured":"Bhatt S, Nagappa AN, Patil CR. Role of oxidative stress in depression. Drug Discov Today. 2020;25:1270\u20136.","journal-title":"Drug Discov Today"},{"key":"1416_CR115","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2021.661455","volume":"8","author":"J De Munter","year":"2021","unstructured":"De Munter J, Pavlov D, Gorlova A, Sicker M, Proshin A, Kalueff AV, et al. Increased oxidative stress in the prefrontal cortex as a shared feature of depressive-and PTSD-like syndromes: effects of a standardized herbal antioxidant. Front Nutr. 2021;8:661455.","journal-title":"Front Nutr"},{"key":"1416_CR116","doi-asserted-by":"publisher","DOI":"10.1089\/ars.2012.5149","author":"S Rizwan","year":"2014","unstructured":"Mittal M, Siddiqui MR, Tran K, Reddy SP, Malik AB.\u00a0Reactive oxygen species in inflammation and tissue injury. Antioxid Redox Signal. 2014;20:1126-67","journal-title":"Antioxid Redox Signal"},{"key":"1416_CR117","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1002\/1873-3468.12964","volume":"592","author":"PR Angelova","year":"2018","unstructured":"Angelova PR, Abramov AY. Role of mitochondrial ROS in the brain: from physiology to neurodegeneration. FEBS Lett. 2018;592:692\u2013702.","journal-title":"FEBS Lett"},{"key":"1416_CR118","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1038\/s41401-022-01022-1","volume":"44","author":"SJ Yang","year":"2023","unstructured":"Yang SJ, Wang JJ, Cheng P, Chen LX, Hu JM, Zhu GQ. Ginsenoside Rg1 in neurological diseases: from bench to bedside. Acta Pharmacol Sin. 2023;44:913\u201330.","journal-title":"Acta Pharmacol Sin"},{"key":"1416_CR119","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1002\/biof.5520340208","volume":"34","author":"E Niki","year":"2008","unstructured":"Niki E. Lipid peroxidation products as oxidative stress biomarkers. BioFactors. 2008;34:171\u201380.","journal-title":"BioFactors"},{"key":"1416_CR120","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1089\/ars.2009.2668","volume":"12","author":"RM Adibhatla","year":"2010","unstructured":"Adibhatla RM, Hatcher JF. Lipid oxidation and peroxidation in CNS health and disease: from molecular mechanisms to therapeutic opportunities. Antioxid Redox Signal. 2010;12:125\u201369.","journal-title":"Antioxid Redox Signal"},{"key":"1416_CR121","doi-asserted-by":"publisher","DOI":"10.1177\/03000605221094995","volume":"50","author":"MA Alvarez-Mon","year":"2022","unstructured":"Alvarez-Mon MA, Ortega MA, Garcia-Montero C, Fraile-Martinez O, Lahera G, Monserrat J, et al. Differential malondialdehyde (MDA) detection in plasma samples of patients with major depressive disorder (MDD): a potential biomarker. J Int Med Res. 2022;50:3000605221094995.","journal-title":"J Int Med Res"},{"key":"1416_CR122","doi-asserted-by":"publisher","first-page":"2499","DOI":"10.1007\/s00204-023-03562-9","volume":"97","author":"K Jomova","year":"2023","unstructured":"Jomova K, Raptova R, Alomar SY, Alwasel SH, Nepovimova E, Kuca K, et al. Reactive oxygen species, toxicity, oxidative stress, and antioxidants: chronic diseases and aging. Arch Toxicol. 2023;97:2499\u2013574.","journal-title":"Arch Toxicol"},{"key":"1416_CR123","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.jare.2021.06.023","volume":"34","author":"Q Zhang","year":"2021","unstructured":"Zhang Q, Liu J, Duan H, Li R, Peng W, Wu C. Activation of Nrf2\/HO-1 signaling: an important molecular mechanism of herbal medicine in the treatment of atherosclerosis via the protection of vascular endothelial cells from oxidative stress. J Adv Res. 2021;34:43\u201363.","journal-title":"J Adv Res"},{"key":"1416_CR124","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpba.2021.114477","volume":"209","author":"S Demirci-Cekic","year":"2022","unstructured":"Demirci-Cekic S, Ozkan G, Avan AN, Uzunboy S, Capanoglu E, Apak R. Biomarkers of oxidative stress and antioxidant defense. J Pharm Biomed Anal. 2022;209:114477.","journal-title":"J Pharm Biomed Anal"},{"key":"1416_CR125","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.ibneur.2024.03.010","volume":"16","author":"A Sanaiee","year":"2024","unstructured":"Sanaiee A, Hassanpour S, Vazir B. Protective role of the ginsenoside Rg1 against methimazole-induced gestational hypothyroidism on reflexive behaviors, conditioned fear and cortical antioxidant levels in mice offspring. IBRO Neurosci Rep. 2024;16:485\u201396.","journal-title":"IBRO Neurosci Rep"},{"key":"1416_CR126","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21207777","volume":"21","author":"L Colucci-D'Amato","year":"2020","unstructured":"Colucci-D\u2019Amato L, Speranza L, Volpicelli F. Neurotrophic factor BDNF, physiological functions and therapeutic potential in depression, neurodegeneration and brain cancer. Int J Mol Sci. 2020;21:7777.","journal-title":"Int J Mol Sci"},{"key":"1416_CR127","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2020.00082","volume":"14","author":"T Yang","year":"2020","unstructured":"Yang T, Nie Z, Shu H, Kuang Y, Chen X, Cheng J, et al. The role of BDNF on neural plasticity in depression. Front Cell Neurosci. 2020;14:82.","journal-title":"Front Cell Neurosci"},{"key":"1416_CR128","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1007\/s12031-020-01754-x","volume":"71","author":"T Rana","year":"2021","unstructured":"Rana T, Behl T, Sehgal A, Srivastava P, Bungau S. Unfolding the role of BDNF as a biomarker for treatment of depression. J Mol Neurosci. 2021;71:2008\u201321.","journal-title":"J Mol Neurosci"},{"key":"1416_CR129","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2022.847572","volume":"16","author":"L Tessarollo","year":"2022","unstructured":"Tessarollo L, Yanpallewar S. TrkB truncated isoform receptors as transducers and determinants of BDNF functions. Front Neurosci. 2022;16:847572.","journal-title":"Front Neurosci"},{"key":"1416_CR130","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2023.122282","volume":"336","author":"Y Wang","year":"2024","unstructured":"Wang Y, Liang J, Xu B, Yang J, Wu Z, Cheng L. TrkB\/BDNF signaling pathway and its small molecular agonists in CNS injury. Life Sci. 2024;336:122282.","journal-title":"Life Sci"},{"key":"1416_CR131","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020.118020","volume":"257","author":"M Amidfar","year":"2020","unstructured":"Amidfar M, de Oliveira J, Kucharska E, Budni J, Kim YK. The role of CREB and BDNF in neurobiology and treatment of Alzheimer\u2019s disease. Life Sci. 2020;257:118020.","journal-title":"Life Sci"},{"key":"1416_CR132","first-page":"140","volume":"6","author":"JY Pan","year":"2017","unstructured":"Pan JY, Zhang F, Sun CC, Li SJ, Li G, Gong FY, et al. miR-134: a human cancer suppressor? Mol Ther. 2017;6:140\u20139.","journal-title":"Mol Ther"},{"key":"1416_CR133","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s11011-022-01124-z","volume":"38","author":"S Vaseghi","year":"2023","unstructured":"Vaseghi S, Mostafavijabbari A, Alizadeh MS, Ghaffarzadegan R, Kholghi G, Zarrindast MR. Intricate role of sleep deprivation in modulating depression: focusing on BDNF, VEGF, serotonin, cortisol, and TNF-alpha. Metab Brain Dis. 2023;38:195\u2013219.","journal-title":"Metab Brain Dis"},{"key":"1416_CR134","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1002\/ddr.21658","volume":"81","author":"E Maffioletti","year":"2020","unstructured":"Maffioletti E, Gennarelli M, Magri C, Bocchio-Chiavetto L, Bortolomasi M, Bonvicini C, et al. Genetic determinants of circulating VEGF levels in major depressive disorder and electroconvulsive therapy response. Drug Dev Res. 2020;81:593\u20139.","journal-title":"Drug Dev Res"},{"key":"1416_CR135","doi-asserted-by":"publisher","DOI":"10.1002\/brb3.2450","volume":"12","author":"Y Feng","year":"2022","unstructured":"Feng Y, Li X, Wang J, Huang X, Meng L, Huang J. Pyruvate kinase M2 (PKM2) improve symptoms of post-ischemic stroke depression by activating VEGF to mediate the MAPK\/ERK pathway. Brain Behav. 2022;12:e2450.","journal-title":"Brain Behav"},{"key":"1416_CR136","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.copsyc.2019.12.002","volume":"34","author":"LD Asarnow","year":"2020","unstructured":"Asarnow LD. Depression and sleep: what has the treatment research revealed and could the HPA axis be a potential mechanism? Curr Opin Psychol. 2020;34:112\u20136.","journal-title":"Curr Opin Psychol"},{"key":"1416_CR137","doi-asserted-by":"publisher","DOI":"10.3390\/brainsci11101298","volume":"11","author":"J Mikulska","year":"2021","unstructured":"Mikulska J, Juszczyk G, Gawronska-Grzywacz M, Herbet M. HPA axis in the pathomechanism of depression and schizophrenia: new therapeutic strategies based on its participation. Brain Sci. 2021;11:1298.","journal-title":"Brain Sci"},{"key":"1416_CR138","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1002\/j.2040-4603.2016.tb00694.x","volume":"6","author":"JP Herman","year":"2016","unstructured":"Herman JP, McKlveen JM, Ghosal S, Kopp B, Wulsin A, Makinson R, et al. Regulation of the hypothalamic-pituitary-adrenocortical stress response. Compr Physiol. 2016;6:603\u201321.","journal-title":"Compr Physiol"},{"key":"1416_CR139","volume-title":"Normal physiology of ACTH and GH release in the hypothalamus and anterior pituitary in man","author":"CT Lim","year":"2025","unstructured":"Lim CT, Khoo B. Normal physiology of ACTH and GH release in the hypothalamus and anterior pituitary in man. South Dartmouth (MA): MDText.com, Inc; 2025."},{"key":"1416_CR140","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/BF00711577","volume":"13","author":"JP Herman","year":"1993","unstructured":"Herman JP. Regulation of adrenocorticosteroid receptor mRNA expression in the central nervous system. Cell Mol Neurobiol. 1993;13:349\u201372.","journal-title":"Cell Mol Neurobiol"},{"key":"1416_CR141","doi-asserted-by":"publisher","first-page":"5016","DOI":"10.1002\/ptr.8075","volume":"38","author":"H Li","year":"2024","unstructured":"Li H, Ge M, Lu B, Wang W, Fu Y, Jiao L, et al. Ginsenosides modulate hypothalamic-pituitary-adrenal function by inhibiting FKBP51 on glucocorticoid receptor to ameliorate depression in mice exposed to chronic unpredictable mild stress. Phytother Res. 2024;38:5016\u201329.","journal-title":"Phytother Res"},{"key":"1416_CR142","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2023.104527","volume":"90","author":"L Liu","year":"2023","unstructured":"Liu L, Wang H, Chen X, Zhang Y, Zhang H, Xie P. Gut microbiota and its metabolites in depression: from pathogenesis to treatment. EBioMedicine. 2023;90:104527.","journal-title":"EBioMedicine"},{"key":"1416_CR143","doi-asserted-by":"publisher","DOI":"10.3390\/nu15143258","volume":"15","author":"RG Xiong","year":"2023","unstructured":"Xiong RG, Li JH, Cheng J, Zhou DD, Wu SX, Huang SY, et al. The role of gut microbiota in anxiety, depression, and other mental disorders as well as the protective effects of dietary components. Nutrients. 2023;15:3258.","journal-title":"Nutrients"},{"key":"1416_CR144","doi-asserted-by":"publisher","DOI":"10.3390\/metabo12010050","volume":"12","author":"MA Ortega","year":"2022","unstructured":"Ortega MA, Alvarez-Mon MA, Garcia-Montero C, Fraile-Martinez O, Guijarro LG, Lahera G, et al. Gut microbiota metabolites in Major Depressive Disorder-deep insights into their pathophysiological role and potential translational applications. Metabolites. 2022;12:50.","journal-title":"Metabolites"},{"key":"1416_CR145","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.brainresbull.2022.02.004","volume":"182","author":"L Chang","year":"2022","unstructured":"Chang L, Wei Y, Hashimoto K. Brain-gut-microbiota axis in depression: a historical overview and future directions. Brain Res Bull. 2022;182:44\u201356.","journal-title":"Brain Res Bull"},{"key":"1416_CR146","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.3390\/ph15101203","volume":"15","author":"Y Jiang","year":"2022","unstructured":"Jiang Y, Zou D, Li Y, Gu S, Dong J, Ma X, et al. Monoamine neurotransmitters control basic emotions and affect major depressive disorders. Pharmaceuticals. 2022;15:1203.","journal-title":"Pharmaceuticals"},{"key":"1416_CR147","doi-asserted-by":"publisher","first-page":"2940","DOI":"10.3390\/ijms26072940","volume":"26","author":"AA Lei","year":"2025","unstructured":"Lei AA, Phang VWX, Lee YZ, Kow ASF, Tham CL, Ho Y-C, et al. Chronic stress-associated depressive disorders: the impact of HPA axis dysregulation and neuroinflammation on the hippocampus\u2014a mini review. Int J Mol Sci. 2025;26:2940.","journal-title":"Int J Mol Sci"},{"key":"1416_CR148","doi-asserted-by":"publisher","first-page":"470","DOI":"10.3390\/antiox12020470","volume":"12","author":"AS Correia","year":"2023","unstructured":"Correia AS, Cardoso A, Vale N. Oxidative stress in depression: the link with the stress response, neuroinflammation, serotonin, neurogenesis and synaptic plasticity. Antioxidants. 2023;12:470.","journal-title":"Antioxidants"},{"key":"1416_CR149","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11011-025-01730-7","volume":"40","author":"RM Mansour","year":"2025","unstructured":"Mansour RM, Rizk NI, Abdel Mageed SS, Alam-Eldein KM, Fahmy HA, Lutfy RH, et al. miRNA dysregulation in depression: unraveling the interplay between neuroplasticity, HPA axis dysfunction, and neuroinflammation. Metab Brain Dis. 2025;40:1\u201321.","journal-title":"Metab Brain Dis"},{"key":"1416_CR150","doi-asserted-by":"publisher","first-page":"1541075","DOI":"10.3389\/fnins.2025.1541075","volume":"19","author":"AG Bertollo","year":"2025","unstructured":"Bertollo AG, Santos CF, Bagatini MD, Ign\u00e1cio ZM. Hypothalamus-pituitary-adrenal and gut-brain axes in biological interaction pathway of the depression. Front Neurosci. 2025;19:1541075.","journal-title":"Front Neurosci"},{"key":"1416_CR151","doi-asserted-by":"publisher","DOI":"10.1111\/cns.70646","volume":"31","author":"D Yang","year":"2025","unstructured":"Yang D, Xu X, Zhuo X, Cai H, Wang H, Liu H, et al. Neuroprotective effects of ginsenoside Rg3 in depressed mice via inhibition of the C1q complement pathway. CNS Neurosci Ther. 2025;31:e70646.","journal-title":"CNS Neurosci Ther"},{"key":"1416_CR152","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2025.157335","volume":"148","author":"W Li","year":"2025","unstructured":"Li W, Kong Z, Yang L, Chen F, Chen Y, Han J, et al. Ginsenoside compound K ameliorates depressive-like behaviors by targeting kynurenine 3-monooxygenase. Phytomedicine. 2025;148:157335.","journal-title":"Phytomedicine"},{"key":"1416_CR153","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2024.156204","volume":"136","author":"Z Dong","year":"2025","unstructured":"Dong Z, Shen Q, Zhu H, Yang Z, Lv J, Feng R, et al. Efficacy and safety of YOXINTINE for depression: a double-blinded, randomized, placebo-controlled, phase 2 clinical trial. Phytomedicine. 2025;136:156204.","journal-title":"Phytomedicine"},{"key":"1416_CR154","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1002\/ptr.6303","volume":"33","author":"Y Li","year":"2019","unstructured":"Li Y, Chen C, Li S, Jiang C. Ginsenoside Rf relieves mechanical hypersensitivity, depression-like behavior, and inflammatory reactions in chronic constriction injury rats. Phytother Res. 2019;33:1095\u2013103.","journal-title":"Phytother Res"},{"key":"1416_CR155","doi-asserted-by":"publisher","first-page":"2470","DOI":"10.1159\/000492684","volume":"48","author":"H Yu","year":"2018","unstructured":"Yu H, Fan C, Yang L, Yu S, Song Q, Wang P, et al. Ginsenoside Rg1 prevents chronic stress-induced depression-like behaviors and neuronal structural plasticity in rats. Cell Physiol Biochem. 2018;48:2470\u201382.","journal-title":"Cell Physiol Biochem"},{"key":"1416_CR156","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.neuropharm.2018.01.009","volume":"131","author":"C Fan","year":"2018","unstructured":"Fan C, Zhu X, Song Q, Wang P, Liu Z, Yu SY. MiR-134 modulates chronic stress-induced structural plasticity and depression-like behaviors via downregulation of Limk1\/cofilin signaling in rats. Neuropharmacology. 2018;131:364\u201376.","journal-title":"Neuropharmacology"},{"key":"1416_CR157","doi-asserted-by":"publisher","first-page":"1878","DOI":"10.1111\/ejn.13255","volume":"44","author":"XZ Zhu","year":"2016","unstructured":"Zhu XZ, Gao R, Liu ZX, Cheng ZY, Qi YH, Fan CQ, et al. Ginsenoside Rg1 reverses stress-induced depression-like behaviours and brain-derived neurotrophic factor expression within the prefrontal cortex. Eur J Neurosci. 2016;44:1878\u201385.","journal-title":"Eur J Neurosci"},{"key":"1416_CR158","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.neuroscience.2016.02.050","volume":"322","author":"Z Liu","year":"2016","unstructured":"Liu Z, Qi Y, Cheng Z, Zhu X, Fan C, Yu SY. The effects of ginsenoside Rg1 on chronic stress induced depression-like behaviors, BDNF expression and the phosphorylation of PKA and CREB in rats. Neuroscience. 2016;322:358\u201369.","journal-title":"Neuroscience"},{"key":"1416_CR159","doi-asserted-by":"publisher","DOI":"10.1080\/14786419.2024.2371997","author":"K NguyenVan","year":"2024","unstructured":"Van KN, Dang TK, Nguyen HT, Honma S, Hoang VD, Vu GTT. Effect of saponins in Panax notoginseng (Burkill) FH Chen on the steroid hormone levels in the chronic unpredictable mild stress model of depression in rats. Nat Prod Res. 2025; 39:6404","journal-title":"Nat Prod Res"},{"key":"1416_CR160","first-page":"1","volume":"32","author":"T Dai","year":"2025","unstructured":"Dai T, Li L, Li J, Tan X, Luo Y, Wang X, et al. Ginsenoside Rh1 inhibits tumor growth in mice with colorectal cancer and depressive symptoms via modulation of the gut microbiota and tumor microenvironment. Mol Med Rep. 2025;32:1\u201317.","journal-title":"Mol Med Rep"},{"key":"1416_CR161","first-page":"2189","volume":"8","author":"J Wang","year":"2016","unstructured":"Wang J, Chen Y, Dai C, Shang Y, Xie J. Ginsenoside Rh2 alleviates tumor-associated depression in a mouse model of colorectal carcinoma. Am J Transl Res. 2016;8:2189\u201395.","journal-title":"Am J Transl Res"},{"key":"1416_CR162","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2025.120011","volume":"351","author":"L Yao","year":"2025","unstructured":"Yao L, Jing R, Wang C, Wang Y, Li X, Wu X, et al. Kai-Xin-San ameliorates fluoxetine-resistant depressive-like behaviors by modulating tryptophan-kynurenine metabolic homeostasis in a rodent model. J Ethnopharmacol. 2025;351:120011.","journal-title":"J Ethnopharmacol"},{"key":"1416_CR163","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.jep.2018.11.020","volume":"231","author":"K Zhang","year":"2019","unstructured":"Zhang K, He M, Su D, Pan X, Li Y, Zhang H, et al. Quantitative proteomics reveal antidepressant potential protein targets of Xiaochaihutang in corticosterone induced model of depression. J Ethnopharmacol. 2019;231:438\u201345.","journal-title":"J Ethnopharmacol"}],"container-title":["Chinese Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13020-026-01416-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13020-026-01416-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13020-026-01416-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T15:03:33Z","timestamp":1778857413000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13020-026-01416-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,15]]},"references-count":163,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1416"],"URL":"https:\/\/doi.org\/10.1186\/s13020-026-01416-x","relation":{},"ISSN":["1749-8546"],"issn-type":[{"value":"1749-8546","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,15]]},"assertion":[{"value":"8 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study does not involve human or animal subjects. All data were sourced from publicly available datasets or literature reviews, and no human or animal experiments were conducted during the research process. Therefore, this study does not require approval from an ethics review board or informed consent from participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Since this study does not involve human or animal subjects and does not utilize any personal identifiable information, no specific consent for publication is required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Jian-Bo Wan serves as a deputy editor of Chinese Medicine. The author was not involved in the review or decision-making process for this manuscript. The authors declare no other conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"133"}}